MannKind (MNKD) Competitors

Alkermes (NASDAQ:ALKS) and MannKind (NASDAQ:MNKD) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, media sentiment, institutional ownership, earnings, dividends and profitability.

Which has more risk and volatility, ALKS or MNKD?

Alkermes has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Comparatively, MannKind has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500.

Do analysts recommend ALKS or MNKD?

Alkermes currently has a consensus price target of $41.08, indicating a potential upside of 38.10%. MannKind has a consensus price target of $9.71, indicating a potential upside of 136.36%. Given MannKind's stronger consensus rating and higher possible upside, analysts plainly believe MannKind is more favorable than Alkermes.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alkermes	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83
MannKind	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25

Which has higher valuation & earnings, ALKS or MNKD?

Alkermes has higher revenue and earnings than MannKind. Alkermes is trading at a lower price-to-earnings ratio than MannKind, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alkermes	$1.56B	3.15	$367.07M	$2.08	14.30
MannKind	$285.50M	4.42	$27.59M	$0.11	37.36

Do insiders and institutionals believe in ALKS or MNKD?

95.2% of Alkermes shares are held by institutional investors. Comparatively, 49.6% of MannKind shares are held by institutional investors. 4.4% of Alkermes shares are held by company insiders. Comparatively, 3.0% of MannKind shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Does the media prefer ALKS or MNKD?

In the previous week, Alkermes had 22 more articles in the media than MannKind. MarketBeat recorded 26 mentions for Alkermes and 4 mentions for MannKind. MannKind's average media sentiment score of 0.92 beat Alkermes' score of 0.59 indicating that MannKind is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alkermes	12 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MannKind	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is ALKS or MNKD more profitable?

Alkermes has a net margin of 23.15% compared to MannKind's net margin of 10.87%. Alkermes' return on equity of 24.86% beat MannKind's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alkermes	23.15%	24.86%	17.14%
MannKind	10.87%	-32.60%	7.81%

Summary

Alkermes beats MannKind on 10 of the 17 factors compared between the two stocks.